Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Global Blood Therapeutics Inc (NASDAQ: GBT)

 
GBT Technical Analysis
5
As on 5th Oct 2022 GBT STOCK Price closed @ 68.49 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 31.77 & Strong Buy for SHORT-TERM with Stoploss of 38.22 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GBTSTOCK Price

Open 68.49 Change Price %
High 68.49 1 Day 0.00 0.00
Low 68.49 1 Week 0.50 0.74
Close 68.49 1 Month 1.27 1.89
Volume N/A 1 Year 26.20 61.95
52 Week High 68.48 | 52 Week Low 22.30
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 141.95 -3.22%
VRPX 0.57 -3.39%
SMCI 33.15 11.62%
LMDX 0.02 0.00%
QUBT 6.10 28.15%
TSLA 352.56 3.80%
PONO 1.72 2.38%
TELL 1.00 0.00%
FLEX 41.30 1.90%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
AMPGW 0.03 200.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
QMCO 9.13 127.11%
BCAC 22.71 125.30%
 
NASDAQ USA Top Losers Stocks
SNAXW 0.00 -100.00%
HOFVW 0.00 -100.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
MILEW 0.06 -53.85%
OCAXW 0.01 -50.00%
LOTZW 0.01 -50.00%
 
 
GBT
Daily Charts		 GBT
Intraday Charts		 Whats New @
Bazaartrend		 GBT
Free Analysis
 
GBT Important Levels Intraday
RESISTANCE68.49
RESISTANCE68.49
RESISTANCE68.49
RESISTANCE68.49
RESISTANCE68.49
RESISTANCE68.49
RESISTANCE68.49
RESISTANCE68.49
 
GBT Forecast November 2024
Share
4th UP Forecast87.43
3rd UP Forecast81.36
2nd UP Forecast77.6
1st UP Forecast73.85
1st DOWN Forecast63.13
2nd DOWN Forecast59.38
3rd DOWN Forecast55.62
4th DOWN Forecast49.55
 
GBT Weekly Forecast
4th UP Forecast75.00
3rd UP Forecast72.91
2nd UP Forecast71.62
1st UP Forecast70.33
1st DOWN Forecast66.65
2nd DOWN Forecast65.36
3rd DOWN Forecast64.07
4th DOWN Forecast61.98
 
GBT Forecast2024
4th UP Forecast167.48
3rd UP Forecast135.73
2nd UP Forecast116.11
1st UP Forecast96.49
1st DOWN Forecast40.49
2nd DOWN Forecast20.87
3rd DOWN Forecast1.25
4th DOWN Forecast-30.5
 
 
GBT Other Details
Segment EQ
Market Capital 2267431680.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
GBT Address
GBT
 
GBT Latest News
 
Your Comments and Response on Global Blood Therapeutics Inc
 
GBT Business Profile
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. The company offers Oxbryta tablets, an oral, once-daily therapy for sickle cell disease (SCD). It is evaluating the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase 2a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing inclacumab, a novel human monoclonal antibody to treat vaso-occlusive crises; and GBT601, a hemoglobin polymerization inhibitor. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD) and beta thalassemia. The company was founded in 2011 and is headquartered in South San Francisco, California. Address: 181 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service